TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10500871
log Bayes Factor = 0.155893
Chromosome 11   position 20,215,756  (GRCh37) Explore rs10500871 on Ensembl!
Variant rs10500871 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C77.1 Intrathoracic lymph nodes
0.411 0.589 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.400 0.600 0.000
C77.3 Axillary and upper limb lymph nodes
0.378 0.622 0.000
C77.8 Lymph nodes of multiple regions
0.366 0.634 0.000
C77.4 Inguinal and lower limb lymph nodes
0.359 0.641 0.000
C77.9 Lymph node, unspecified
0.349 0.651 0.000
C77.5 Intrapelvic lymph nodes
0.343 0.657 0.000
C77.0 Lymph nodes of head, face and neck
0.150 0.850 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.116 0.884 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.092 0.908 0.000
C78.0 Secondary malignant neoplasm of lung
0.091 0.909 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.088 0.912 0.000
C80 Malignant neoplasm without specification of site
0.086 0.914 0.000
C78.7 Secondary malignant neoplasm of liver
0.082 0.918 0.000
C77.2 Intra-abdominal lymph nodes
0.079 0.921 0.000
C76.1 Thorax
0.078 0.922 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.065 0.935 0.000
C76.2 Abdomen
0.064 0.936 0.000
C76.8 Overlapping lesion of other and ill-defined sites
0.063 0.936 0.000
C76.7 Other ill-defined sites
0.063 0.936 0.000
C76.5 Lower limb
0.063 0.936 0.000
C76.4 Upper limb
0.063 0.936 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.062 0.937 0.000
C78.2 Secondary malignant neoplasm of pleura
0.062 0.938 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.062 0.938 0.000
C80.9 Malignant neoplasm, unspecified
0.061 0.939 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.059 0.941 0.000
C76.3 Pelvis
0.055 0.944 0.000
C76.0 Head, face and neck
0.053 0.947 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.049 0.951 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.040 0.960 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.029 0.971 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.028 0.972 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.027 0.973 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.027 0.973 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.026 0.974 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.025 0.975 0.000
T39.1 4-Aminophenol derivatives
0.025 0.975 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.024 0.976 0.000
T47.4 Other laxatives
0.024 0.976 0.000
T46.1 Calcium-channel blockers
0.024 0.976 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.023 0.976 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.024 0.976 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.024 0.976 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.023 0.977 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.023 0.977 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.023 0.977 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.023 0.977 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.022 0.978 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.022 0.978 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.021 0.979 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.021 0.979 0.000
T46.7 Peripheral vasodilators
0.021 0.979 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.021 0.979 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.021 0.979 0.000
T36 Poisoning by systemic antibiotics
0.021 0.979 0.000
T47.2 Stimulant laxatives
0.020 0.980 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.020 0.980 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.020 0.980 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.020 0.980 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.019 0.981 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.019 0.981 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.019 0.981 0.000
T47.7 Emetics
0.019 0.981 0.000
T47.6 Antidiarrhoeal drugs
0.019 0.981 0.000
T47.5 Digestants
0.019 0.981 0.000
T47.3 Saline and osmotic laxatives
0.019 0.981 0.000
T47.0 Histamine H(2)-receptor antagonists
0.019 0.981 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.019 0.981 0.000
T39.4 Antirheumatics, not elsewhere classified
0.019 0.981 0.000
T39.2 Pyrazolone derivatives
0.019 0.981 0.000
C79 Secondary malignant neoplasm of other sites
0.019 0.981 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.018 0.982 0.000
T42.3 Barbiturates
0.018 0.982 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.018 0.982 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.018 0.982 0.000
T43.9 Psychotropic drug, unspecified
0.017 0.982 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.017 0.982 0.000
C79.6 Secondary malignant neoplasm of ovary
0.017 0.983 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.017 0.983 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.017 0.983 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.017 0.983 0.000
T43.6 Psychostimulants with abuse potential
0.017 0.983 0.000
T42.0 Hydantoin derivatives
0.017 0.983 0.000
T42.1 Iminostilbenes
0.017 0.983 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.016 0.983 0.000
T40.6 Other and unspecified narcotics
0.016 0.983 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.016 0.983 0.000
T42.2 Succinimides and oxazolidinediones
0.016 0.983 0.000
T36.4 Tetracyclines
0.016 0.984 0.000
T36.3 Macrolides
0.016 0.984 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.015 0.985 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.015 0.985 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.015 0.985 0.000
T36.9 Systemic antibiotic, unspecified
0.015 0.985 0.000
T36.8 Other systemic antibiotics
0.015 0.985 0.000
T36.7 Antifungal antibiotics, systemically used
0.015 0.985 0.000
T36.6 Rifamycins
0.015 0.985 0.000
T36.5 Aminoglycosides
0.015 0.985 0.000
T36.2 Chloramphenicol group
0.015 0.985 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.015 0.985 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.015 0.985 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.015 0.985 0.000
T38.1 Thyroid hormones and substitutes
0.015 0.985 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.014 0.985 0.000
T49.9 Topical agent, unspecified
0.014 0.985 0.000
T49.8 Other topical agents
0.014 0.985 0.000
T49.7 Dental drugs, topically applied
0.014 0.985 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.014 0.985 0.000
T49.5 Ophthalmological drugs and preparations
0.014 0.985 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.014 0.985 0.000
T49.3 Emollients, demulcents and protectants
0.014 0.985 0.000
T49.2 Local astringents and local detergents
0.014 0.985 0.000
T49.1 Antipruritics
0.014 0.985 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.014 0.985 0.000
T40.8 Lysergide [LSD]
0.014 0.985 0.000
T40.7 Cannabis (derivatives)
0.014 0.985 0.000
T40.5 Cocaine
0.014 0.985 0.000
T40.3 Methadone
0.014 0.985 0.000
T40.1 Heroin
0.014 0.985 0.000
T40.0 Opium
0.014 0.985 0.000
T41.5 Therapeutic gases
0.014 0.986 0.000
T41.4 Anaesthetic, unspecified
0.014 0.986 0.000
T41.3 Local anaesthetics
0.014 0.986 0.000
T41.2 Other and unspecified general anaesthetics
0.014 0.986 0.000
T41.1 Intravenous anaesthetics
0.014 0.986 0.000
T41.0 Inhaled anaesthetics
0.014 0.986 0.000
T38.9 Other and unspecified hormone antagonists
0.014 0.986 0.000
T38.7 Androgens and anabolic congeners
0.014 0.986 0.000
T38.5 Other oestrogens and progestogens
0.014 0.986 0.000
T38.4 Oral contraceptives
0.014 0.986 0.000
T38.2 Antithyroid drugs
0.014 0.986 0.000
T38.0 Glucocorticoids and synthetic analogues
0.014 0.986 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.014 0.986 0.000
T48.5 Anti-common-cold drugs
0.014 0.986 0.000
T48.4 Expectorants
0.014 0.986 0.000
T48.3 Antitussives
0.014 0.986 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.014 0.986 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.014 0.986 0.000
T48.0 Oxytocic drugs
0.014 0.986 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.014 0.986 0.000
T36.0 Penicillins
0.014 0.986 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.014 0.986 0.000
T42.4 Benzodiazepines
0.014 0.986 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.014 0.986 0.000
T40.2 Other opioids
0.014 0.986 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.013 0.986 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.013 0.987 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.013 0.987 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.013 0.987 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.013 0.987 0.000
T44.0 Anticholinesterase agents
0.013 0.987 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.013 0.987 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.013 0.987 0.000
T37.5 Antiviral drugs
0.013 0.987 0.000
T37.4 Anthelminthics
0.013 0.987 0.000
T37.3 Other antiprotozoal drugs
0.013 0.987 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.013 0.987 0.000
T37.1 Antimycobacterial drugs
0.013 0.987 0.000
T37.0 Sulphonamides
0.013 0.987 0.000
E66.9 Obesity, unspecified
0.013 0.987 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.012 0.987 0.000
T40.4 Other synthetic narcotics
0.012 0.988 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.012 0.988 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.012 0.988 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.012 0.988 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.012 0.988 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.012 0.988 0.000
T39.0 Salicylates
0.012 0.988 0.000
D11.0 Parotid gland
0.000 0.988 0.012
T37.8 Other specified systemic anti-infectives and antiparasitics
0.011 0.989 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.011 0.989 0.000
T50.7 Analeptics and opioid receptor antagonists
0.011 0.989 0.000
T50.5 Appetite depressants
0.011 0.989 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.011 0.989 0.000
T50.1 Loop [high-ceiling] diuretics
0.011 0.989 0.000
T50.0 Mineralocorticoids and their antagonists
0.011 0.989 0.000
T50.8 Diagnostic agents
0.010 0.990 0.000
T43.2 Other and unspecified antidepressants
0.010 0.990 0.000
T14.0 Superficial injury of unspecified body region
0.010 0.990 0.000
T50.4 Drugs affecting uric acid metabolism
0.010 0.990 0.000
K31.9 Disease of stomach and duodenum, unspecified
0.000 0.991 0.009
C79.2 Secondary malignant neoplasm of skin
0.008 0.992 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.008 0.992 0.000
T45.8 Other primarily systemic and haematological agents
0.008 0.992 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.008 0.992 0.000
T45.6 Fibrinolysis-affecting drugs
0.008 0.992 0.000
T45.4 Iron and its compounds
0.008 0.992 0.000
T45.3 Enzymes, not elsewhere classified
0.008 0.992 0.000
T14 Injury of unspecified body region
0.008 0.992 0.000
L81.4 Other melanin hyperpigmentation
0.008 0.992 0.000
T45.2 Vitamins, not elsewhere classified
0.008 0.992 0.000
T14.9 Injury, unspecified
0.008 0.992 0.000
T45.0 Antiallergic and antiemetic drugs
0.007 0.992 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.008 0.992 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.007 0.993 0.000
Y43.3 Other antineoplastic drugs
0.007 0.993 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.007 0.993 0.000
Z90.3 Acquired absence of part of stomach
0.000 0.993 0.007
T14.3 Dislocation, sprain and strain of unspecified body region
0.007 0.993 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.006 0.993 0.000
T14.1 Open wound of unspecified body region
0.007 0.993 0.000
M41.99 Scoliosis, unspecified (Site unspecified)
0.000 0.994 0.006
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction
0.006 0.994 0.000
T14.2 Fracture of unspecified body region
0.006 0.994 0.000
T14.8 Other injuries of unspecified body region
0.006 0.994 0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region
0.006 0.994 0.000
T14.5 Injury of blood vessel(s) of unspecified body region
0.006 0.994 0.000
T14.4 Injury of nerve(s) of unspecified body region
0.006 0.994 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.006 0.994 0.000
K56.2 Volvulus
0.000 0.994 0.006
G81.9 Hemiplegia, unspecified
0.006 0.994 0.000
T45.5 Anticoagulants
0.005 0.994 0.000
M85.89 Other specified disorders of bone density and structure (Site unspecified)
0.006 0.994 0.000
T14.6 Injury of tendons and muscles of unspecified body region
0.005 0.995 0.000
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)
0.005 0.995 0.000
E66 Obesity
0.005 0.995 0.000
R07.1 Chest pain on breathing
0.005 0.995 0.000
M85.8 Other specified disorders of bone density and structure
0.005 0.995 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.005 0.995 0.000
Z36.0 Antenatal screening for chromosomal anomalies
0.005 0.995 0.000
M85.87 Other specified disorders of bone density and structure (Ankle and foot)
0.005 0.995 0.000
T14.21 Fracture of unspecified body region (open)
0.004 0.995 0.000
T14.20 Fracture of unspecified body region (closed)
0.004 0.995 0.000
I34.1 Mitral (valve) prolapse
0.005 0.995 0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.004 0.996 0.000
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus
0.004 0.996 0.000
D11 Benign neoplasm of major salivary glands
0.000 0.996 0.004
E66.0 Obesity due to excess calories
0.004 0.996 0.000
E66.1 Drug-induced obesity
0.004 0.996 0.000
M85.83 Other specified disorders of bone density and structure (Forearm)
0.004 0.996 0.000
M85.84 Other specified disorders of bone density and structure (Hand)
0.004 0.996 0.000
M85.82 Other specified disorders of bone density and structure (Upper arm)
0.004 0.996 0.000
M85.81 Other specified disorders of bone density and structure (Shoulder region)
0.004 0.996 0.000
O35 Maternal care for known or suspected foetal abnormality and damage
0.004 0.996 0.000
M85.88 Other specified disorders of bone density and structure (Other)
0.004 0.996 0.000
G55.0 Nerve root and plexus compressions in neoplastic disease
0.004 0.996 0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.000 0.996 0.004
L81 Other disorders of pigmentation
0.004 0.996 0.000
F81.9 Developmental disorder of scholastic skills, unspecified
0.000 0.996 0.004
D11.9 Major salivary gland, unspecified
0.000 0.996 0.003
M85.80 Other specified disorders of bone density and structure (Multiple sites)
0.003 0.996 0.000
Y43 Primarily systemic agents
0.004 0.996 0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified
0.003 0.996 0.000
C92.0 Acute myeloid leukaemia
0.003 0.997 0.000
Z36 Antenatal screening
0.003 0.997 0.000
C92.1 Chronic myeloid leukaemia
0.003 0.997 0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage
0.003 0.997 0.000
O42.0 Premature rupture of membranes, onset of labour within 24 hours
0.003 0.997 0.000
M85.86 Other specified disorders of bone density and structure (Lower leg)
0.003 0.997 0.000
K25.7 Chronic without haemorrhage or perforation
0.000 0.997 0.003
I69.8 Sequelae of other and unspecified cerebrovascular diseases
0.003 0.997 0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.003 0.997 0.000
Z36.8 Other antenatal screening
0.003 0.997 0.000
E65 Localised adiposity
0.003 0.997 0.000
L89.1 Stage II decubitus ulcer
0.000 0.997 0.003
E65-E68 Obesity and other hyperalimentation
0.003 0.997 0.000
M54.49 Lumbago with sciatica (Site unspecified)
0.000 0.997 0.003
I69 Sequelae of cerebrovascular disease
0.003 0.997 0.000
I69.0 Sequelae of subarachnoid haemorrhage
0.003 0.997 0.000
Y43.1 Antineoplastic antimetabolites
0.003 0.997 0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods
0.003 0.997 0.000
H10.9 Conjunctivitis, unspecified
0.003 0.997 0.000
L81.8 Other specified disorders of pigmentation
0.003 0.997 0.000
C92 Myeloid leukaemia
0.003 0.997 0.000
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures
0.003 0.997 0.000
O35.6 Maternal care for (suspected) damage to foetus by radiation
0.003 0.997 0.000
O35.5 Maternal care for (suspected) damage to foetus by drugs
0.003 0.997 0.000
O35.4 Maternal care for (suspected) damage to foetus from alcohol
0.003 0.997 0.000
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother
0.003 0.997 0.000
O35.2 Maternal care for (suspected) hereditary disease in foetus
0.003 0.997 0.000
Z36.9 Antenatal screening, unspecified
0.003 0.997 0.000
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)
0.003 0.997 0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods
0.003 0.997 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.003 0.997 0.000
O34.3 Maternal care for cervical incompetence
0.003 0.997 0.000
T13 Other injuries of lower limb, level unspecified
0.003 0.997 0.000
L81.7 Pigmented purpuric dermatosis
0.003 0.997 0.000
L81.6 Other disorders of diminished melanin formation
0.003 0.997 0.000
L81.5 Leukoderma, not elsewhere classified
0.003 0.997 0.000
L81.3 Cafe au lait spots
0.003 0.997 0.000
L81.1 Chloasma
0.003 0.997 0.000
L81.0 Postinflammatory hyperpigmentation
0.003 0.997 0.000
Z36.1 Antenatal screening for raised alphafetoprotein level
0.003 0.997 0.000
C92.7 Other myeloid leukaemia
0.003 0.997 0.000
Y43.9 Primarily systemic agent, unspecified
0.003 0.997 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.003 0.997 0.000
Y43.6 Enzymes, not elsewhere classified
0.003 0.997 0.000
Y43.5 Acidifying and alkalising agents
0.003 0.997 0.000
Y43.2 Antineoplastic natural products
0.003 0.997 0.000
L81.9 Disorder of pigmentation, unspecified
0.003 0.997 0.000
O35.0 Maternal care for (suspected) central nervous system malformation in foetus
0.003 0.997 0.000
Z98.2 Presence of cerebrospinal fluid drainage device
0.000 0.997 0.003
M25.47 Effusion of joint (Ankle and foot)
0.003 0.997 0.000
Z36.5 Antenatal screening for isoimmunisation
0.003 0.997 0.000
R94.3 Abnormal results of cardiovascular function studies
0.000 0.997 0.003
K66.8 Other specified disorders of peritoneum
0.003 0.997 0.000
Y43.4 Immunosuppressive agents
0.003 0.997 0.000
H73.8 Other specified disorders of tympanic membrane
0.000 0.997 0.003
O34.2 Maternal care due to uterine scar from previous surgery
0.003 0.997 0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid
0.000 0.997 0.003
L81.2 Freckles
0.003 0.997 0.000
O34 Maternal care for known or suspected abnormality of pelvic organs
0.003 0.997 0.000
T12.X1 Fracture of lower limb, level unspecified (open)
0.003 0.997 0.000
T12.X0 Fracture of lower limb, level unspecified (closed)
0.003 0.997 0.000
T12 Fracture of lower limb, level unspecified
0.003 0.997 0.000
T10.X1 Fracture of upper limb, level unspecified (open)
0.003 0.997 0.000
T10.X0 Fracture of upper limb, level unspecified (closed)
0.003 0.997 0.000
T10 Fracture of upper limb, level unspecified
0.003 0.997 0.000
T08.X1 Fracture of spine, level unspecified (open)
0.003 0.997 0.000
T08.X0 Fracture of spine, level unspecified (closed)
0.003 0.997 0.000
Y43.0 Antiallergic and antiemetic drugs
0.003 0.997 0.000
T08 Fracture of spine, level unspecified
0.002 0.997 0.000
T13.1 Open wound of lower limb, level unspecified
0.002 0.997 0.000
E67 Other hyperalimentation
0.002 0.997 0.000
E68 Sequelae of hyperalimentation
0.002 0.997 0.000
O30.0 Twin pregnancy
0.003 0.997 0.000
T09 Other injuries of spine and trunk, level unspecified
0.002 0.997 0.000
D86.0 Sarcoidosis of lung
0.000 0.997 0.003
C92.5 Acute myelomonocytic leukaemia
0.002 0.997 0.000
M94.86 Other specified disorders of cartilage (Lower leg)
0.000 0.997 0.003
D25.0 Submucous leiomyoma of uterus
0.000 0.997 0.003
H80.9 Otosclerosis, unspecified
0.000 0.997 0.003
Z73.3 Stress, not elsewhere classified
0.003 0.997 0.000
O42 Premature rupture of membranes
0.003 0.997 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.002 0.998 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.002 0.998 0.000
C92.3 Myeloid sarcoma
0.002 0.998 0.000
C92.2 Subacute myeloid leukaemia
0.002 0.998 0.000
C92.4 Acute promyelocytic leukaemia
0.002 0.998 0.000
C92.9 Myeloid leukaemia, unspecified
0.002 0.998 0.000
E66.8 Other obesity
0.002 0.998 0.000
Q38.7 Pharyngeal pouch
0.002 0.998 0.000
O30 Multiple gestation
0.002 0.998 0.000
O40 Polyhydramnios
0.002 0.998 0.000
M22.4 Chondromalacia patellae
0.002 0.998 0.000
O34.7 Maternal care for abnormality of vulva and perineum
0.002 0.998 0.000
T13.9 Unspecified injury of lower limb, level unspecified
0.002 0.998 0.000
T13.8 Other specified injuries of lower limb, level unspecified
0.002 0.998 0.000
T13.6 Traumatic amputation of lower limb, level unspecified
0.002 0.998 0.000
T13.5 Injury of unspecified muscle and tendon of lower limb, level unspecified
0.002 0.998 0.000
T13.4 Injury of unspecified blood vessel of lower limb, level unspecified
0.002 0.998 0.000
T13.3 Injury of unspecified nerve of lower limb, level unspecified
0.002 0.998 0.000
T13.2 Dislocation, strain and sprain of unspecified joint and ligament of lower limb, level unspecified
0.002 0.998 0.000
X41.9 Unspecified place
0.002 0.998 0.000
D11.7 Other major salivary glands
0.000 0.998 0.002
T13.0 Superficial injury of lower limb, level unspecified
0.002 0.998 0.000
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems
0.002 0.998 0.000
Q53.1 Undescended testicle, unilateral
0.000 0.998 0.002
A04.7 Enterocolitis due to Clostridium difficile
0.002 0.998 0.000
O34.4 Maternal care for other abnormalities of cervix
0.002 0.998 0.000
O34.0 Maternal care for congenital malformation of uterus
0.002 0.998 0.000
G81 Hemiplegia
0.002 0.998 0.000
O32.2 Maternal care for transverse and oblique lie
0.002 0.998 0.000
T09.0 Superficial injury of trunk, level unspecified
0.002 0.998 0.000
G80.9 Infantile cerebral palsy, unspecified
0.000 0.998 0.002
T11 Other injuries of upper limb, level unspecified
0.002 0.998 0.000
H74.4 Polyp of middle ear
0.000 0.998 0.002
O34.9 Maternal care for abnormality of pelvic organ, unspecified
0.002 0.998 0.000
O34.6 Maternal care for abnormality of vagina
0.002 0.998 0.000
O34.5 Maternal care for other abnormalities of gravid uterus
0.002 0.998 0.000
O46.9 Antepartum haemorrhage, unspecified
0.002 0.998 0.000
S82.50 Fracture of medial malleolus (closed)
0.000 0.998 0.002
D37.4 Colon
0.000 0.998 0.002
E67.8 Other specified hyperalimentation
0.002 0.998 0.000
E67.3 Hypervitaminosis D
0.002 0.998 0.000
E67.2 Megavitamin-B6 syndrome
0.002 0.998 0.000
E67.1 Hypercarotenaemia
0.002 0.998 0.000
E67.0 Hypervitaminosis A
0.002 0.998 0.000
H74.0 Tympanosclerosis
0.000 0.998 0.002
T09.8 Other specified injuries of trunk, level unspecified
0.002 0.998 0.000
T09.6 Traumatic amputation of trunk, level unspecified
0.002 0.998 0.000
T09.5 Injury of unspecified muscle and tendon of trunk
0.002 0.998 0.000
T09.4 Injury of unspecified nerve, spinal nerve root and plexus of trunk
0.002 0.998 0.000
T09.1 Open wound of trunk, level unspecified
0.002 0.998 0.000
H21.5 Other adhesions and disruptions of iris and ciliary body
0.000 0.998 0.002
I69.2 Sequelae of other nontraumatic intracranial haemorrhage
0.002 0.998 0.000
T09.9 Unspecified injury of trunk, level unspecified
0.002 0.998 0.000
E10.1 With ketoacidosis
0.000 0.998 0.002
T09.3 Injury of spinal cord, level unspecified
0.002 0.998 0.000
F81 Specific developmental disorders of scholastic skills
0.000 0.998 0.002
M85 Other disorders of bone density and structure
0.002 0.998 0.000
O46 Antepartum haemorrhage, not elsewhere classified
0.002 0.998 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.002 0.998 0.000
O42.2 Premature rupture of membranes, labour delayed by therapy
0.002 0.998 0.000
E61.1 Iron deficiency
0.000 0.998 0.002
M85.4 Solitary bone cyst
0.002 0.998 0.000
T09.2 Dislocation, strain and sprain of unspecified joint and ligament of trunk
0.002 0.998 0.000
M85.46 Solitary bone cyst (Lower leg)
0.002 0.998 0.000
O30.9 Multiple gestation, unspecified
0.002 0.998 0.000
O30.8 Other multiple gestation
0.002 0.998 0.000
O30.2 Quadruplet pregnancy
0.002 0.998 0.000
Z36.2 Other antenatal screening based on amniocentesis
0.002 0.998 0.000
O32 Maternal care for known or suspected malpresentation of foetus
0.002 0.998 0.000
H74.8 Other specified disorders of middle ear and mastoid
0.000 0.998 0.002
I70.2 Atherosclerosis of arteries of the extremities
0.002 0.998 0.000
O32.0 Maternal care for unstable lie
0.002 0.998 0.000
N91.2 Amenorrhoea, unspecified
0.002 0.998 0.000
G81.0 Flaccid hemiplegia
0.002 0.998 0.000
O30.1 Triplet pregnancy
0.002 0.998 0.000
O31 Complications specific to multiple gestation
0.002 0.998 0.000
R41.2 Retrograde amnesia
0.000 0.998 0.002
H74 Other disorders of middle ear and mastoid
0.000 0.998 0.002
T11.9 Unspecified injury of upper limb, level unspecified
0.002 0.998 0.000
T11.8 Other specified injuries of upper limb, level unspecified
0.002 0.998 0.000
T11.6 Traumatic amputation of upper limb, level unspecified
0.002 0.998 0.000
T11.5 Injury of unspecified muscle and tendon of upper limb, level unspecified
0.002 0.998 0.000
T11.4 Injury of unspecified blood vessel of upper limb, level unspecified
0.002 0.998 0.000
T11.3 Injury of unspecified nerve of upper limb, level unspecified
0.002 0.998 0.000
T11.2 Dislocation, strain and sprain of unspecified joint and ligament of upper limb, level unspecified
0.002 0.998 0.000
H73 Other disorders of tympanic membrane
0.000 0.998 0.002
O33 Maternal care for known or suspected disproportion
0.002 0.998 0.000
K66.1 Haemoperitoneum
0.002 0.998 0.000
O42.9 Premature rupture of membranes, unspecified
0.002 0.998 0.000
Z85.6 Personal history of leukaemia
0.002 0.998 0.000
F81.8 Other developmental disorders of scholastic skills
0.000 0.998 0.002
F81.3 Mixed disorder of scholastic skills
0.000 0.998 0.002
F81.2 Specific disorder of arithmetical skills
0.000 0.998 0.002
F81.1 Specific spelling disorder
0.000 0.998 0.002
F81.0 Specific reading disorder
0.000 0.998 0.002
H73.9 Disorder of tympanic membrane, unspecified
0.000 0.998 0.002
I69.3 Sequelae of cerebral infarction
0.002 0.998 0.000
M85.5 Aneurysmal bone cyst
0.002 0.998 0.000
M85.3 Osteitis condensans
0.002 0.998 0.000
M85.1 Skeletal fluorosis
0.002 0.998 0.000
O46.0 Antepartum haemorrhage with coagulation defect
0.002 0.998 0.000
O32.6 Maternal care for compound presentation
0.002 0.998 0.000
O34.8 Maternal care for other abnormalities of pelvic organs
0.002 0.998 0.000
T91.2 Sequelae of other fracture of thorax and pelvis
0.000 0.998 0.002
O41 Other disorders of amniotic fluid and membranes
0.002 0.998 0.000
O45 Premature separation of placenta [abruptio placentae]
0.002 0.998 0.000
M85.49 Solitary bone cyst (Site unspecified)
0.001 0.998 0.000
M85.48 Solitary bone cyst (Other)
0.001 0.998 0.000
M85.47 Solitary bone cyst (Ankle and foot)
0.001 0.998 0.000
M85.45 Solitary bone cyst (Pelvic region and thigh)
0.001 0.998 0.000
M85.44 Solitary bone cyst (Hand)
0.001 0.998 0.000
M85.43 Solitary bone cyst (Forearm)
0.001 0.998 0.000
M85.42 Solitary bone cyst (Upper arm)
0.001 0.998 0.000
M85.41 Solitary bone cyst (Shoulder region)
0.001 0.998 0.000
M85.40 Solitary bone cyst (Multiple sites)
0.001 0.998 0.000
M85.9 Disorder of bone density and structure, unspecified
0.002 0.998 0.000
O32.9 Maternal care for malpresentation of foetus, unspecified
0.002 0.998 0.000
R52.0 Acute pain
0.002 0.998 0.000
Z09.9 Follow-up examination after unspecified treatment for other conditions
0.000 0.998 0.002
M85.68 Other cyst of bone (Other)
0.002 0.998 0.000
M85.6 Other cyst of bone
0.002 0.998 0.000
T11.0 Superficial injury of upper limb, level unspecified
0.001 0.998 0.000
J69.0 Pneumonitis due to food and vomit
0.000 0.998 0.002
Z80.5 Family history of malignant neoplasm of urinary tract
0.000 0.998 0.002
H74.9 Disorder of middle ear and mastoid, unspecified
0.000 0.998 0.002
M25.4 Effusion of joint
0.002 0.998 0.000
O31.2 Continuing pregnancy after intra-uterine death of one foetus or more
0.001 0.998 0.000
Z31.4 Procreative investigation and testing
0.002 0.998 0.000
M25.44 Effusion of joint (Hand)
0.002 0.998 0.000
M85.2 Hyperostosis of skull
0.001 0.998 0.000
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)
0.002 0.998 0.000
W24.9 Unspecified place
0.002 0.998 0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
M25.42 Effusion of joint (Upper arm)
0.002 0.998 0.000
O31.1 Continuing pregnancy after abortion of one foetus or more
0.001 0.998 0.000
O31.0 Papyraceous foetus
0.001 0.998 0.000
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more
0.002 0.998 0.000
T11.1 Open wound of upper limb, level unspecified
0.001 0.998 0.000
O43 Placental disorders
0.002 0.998 0.000
H73.1 Chronic myringitis
0.000 0.998 0.001
H74.2 Discontinuity and dislocation of ear ossicles
0.000 0.998 0.001
O33.8 Maternal care for disproportion of other origin
0.001 0.998 0.000
O33.7 Maternal care for disproportion due to other foetal deformities
0.001 0.998 0.000
O33.6 Maternal care for disproportion due to hydrocephalic foetus
0.001 0.998 0.000
O33.5 Maternal care for disproportion due to unusually large foetus
0.001 0.998 0.000
O33.4 Maternal care for disproportion of mixed maternal and foetal origin
0.001 0.998 0.000
O33.3 Maternal care for disproportion due to outlet contraction of pelvis
0.001 0.998 0.000
O33.2 Maternal care for disproportion due to inlet contraction of pelvis
0.001 0.998 0.000
O33.1 Maternal care for disproportion due to generally contracted pelvis
0.001 0.998 0.000
O33.0 Maternal care for disproportion due to deformity of maternal pelvic bones
0.001 0.998 0.000
O32.4 Maternal care for high head at term
0.001 0.998 0.000
O31.8 Other complications specific to multiple gestation
0.001 0.998 0.000
Q38 Other congenital malformations of tongue, mouth and pharynx
0.002 0.998 0.000
M85.19 Skeletal fluorosis (Site unspecified)
0.001 0.998 0.000
M85.18 Skeletal fluorosis (Other)
0.001 0.998 0.000
M85.17 Skeletal fluorosis (Ankle and foot)
0.001 0.998 0.000
M85.16 Skeletal fluorosis (Lower leg)
0.001 0.998 0.000
M85.15 Skeletal fluorosis (Pelvic region and thigh)
0.001 0.998 0.000
M85.14 Skeletal fluorosis (Hand)
0.001 0.998 0.000
M85.13 Skeletal fluorosis (Forearm)
0.001 0.998 0.000
M85.12 Skeletal fluorosis (Upper arm)
0.001 0.998 0.000
M85.11 Skeletal fluorosis (Shoulder region)
0.001 0.998 0.000
M85.10 Skeletal fluorosis (Multiple sites)
0.001 0.998 0.000
M85.39 Osteitis condensans (Site unspecified)
0.001 0.998 0.000
M85.38 Osteitis condensans (Other)
0.001 0.998 0.000
M85.37 Osteitis condensans (Ankle and foot)
0.001 0.998 0.000
M85.36 Osteitis condensans (Lower leg)
0.001 0.998 0.000
M85.35 Osteitis condensans (Pelvic region and thigh)
0.001 0.998 0.000
M85.34 Osteitis condensans (Hand)
0.001 0.998 0.000
M85.33 Osteitis condensans (Forearm)
0.001 0.998 0.000
M85.32 Osteitis condensans (Upper arm)
0.001 0.998 0.000
M85.31 Osteitis condensans (Shoulder region)
0.001 0.998 0.000
M85.30 Osteitis condensans (Multiple sites)
0.001 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.